Ceptaris Therapeutics, Inc has raised $10 million through a Series D-1 private placement of preferred stock.
Osage and BioAdvance
Breaking News
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Tesla Shareholder Asks Judge to Prevent Elon Musk From Moving Pay Fight to Texas to Evade Delaware Ruling
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
- Amazon Top Aggregator Thrasio Loses CEO, 5 Other Senior Execs Following Bankruptcy Filing
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?